Investor Guide: Health & Biotech FY2023

September 28, 2022

Prescient Therapeutics (ASX: PTX) featured in the ‘Investor Guide for Health & Biotech’ by The Australian and Stockhead, outlining the Company’s deep pipeline.

Related Post

×